These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 27880728

  • 1. Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.
    Guerriero I, D'Angelo D, Pallante P, Santos M, Scrima M, Malanga D, De Marco C, Ravo M, Weisz A, Laudanna C, Ceccarelli M, Falco G, Rizzuto A, Viglietto G.
    Oncotarget; 2017 Mar 21; 8(12):19172-19191. PubMed ID: 27880728
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 21; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 3. Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
    De Marco C, Laudanna C, Rinaldo N, Oliveira DM, Ravo M, Weisz A, Ceccarelli M, Caira E, Rizzuto A, Zoppoli P, Malanga D, Viglietto G.
    PLoS One; 2017 Jul 21; 12(6):e0178865. PubMed ID: 28662101
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J, Wert-Lamas L, Santisteban P.
    Oncogene; 2018 Jun 21; 37(25):3369-3383. PubMed ID: 29353884
    [Abstract] [Full Text] [Related]

  • 5. Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase.
    Scrima M, De Marco C, Fabiani F, Franco R, Pirozzi G, Rocco G, Ravo M, Weisz A, Zoppoli P, Ceccarelli M, Botti G, Malanga D, Viglietto G.
    PLoS One; 2012 Jun 21; 7(2):e30427. PubMed ID: 22363436
    [Abstract] [Full Text] [Related]

  • 6. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 Jun 21; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.
    Ling C, Wang X, Zhu J, Tang H, Du W, Zeng Y, Sun L, Huang JA, Liu Z.
    Cancer Med; 2019 Jul 21; 8(7):3520-3531. PubMed ID: 31074594
    [Abstract] [Full Text] [Related]

  • 8. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
    Trigka EA, Levidou G, Saetta AA, Chatziandreou I, Tomos P, Thalassinos N, Anastasiou N, Spartalis E, Kavantzas N, Patsouris E, Korkolopoulou P.
    Oncol Rep; 2013 Aug 21; 30(2):623-36. PubMed ID: 23728071
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
    Miao Y, Zheng W, Li N, Su Z, Zhao L, Zhou H, Jia L.
    Sci Rep; 2017 Feb 06; 7():41942. PubMed ID: 28165066
    [Abstract] [Full Text] [Related]

  • 10. miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway.
    Bu W, Luo T.
    DNA Cell Biol; 2017 Nov 06; 36(11):976-982. PubMed ID: 28872922
    [Abstract] [Full Text] [Related]

  • 11. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.
    Cai J, Fang L, Huang Y, Li R, Yuan J, Yang Y, Zhu X, Chen B, Wu J, Li M.
    Cancer Res; 2013 Sep 01; 73(17):5402-15. PubMed ID: 23856247
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y, Wang LQ, Guo QY, Shi TL.
    Int J Clin Exp Pathol; 2015 Sep 01; 8(3):2461-72. PubMed ID: 26045752
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route.
    Sun B, Hu N, Cong D, Chen K, Li J.
    Bioengineered; 2021 Dec 01; 12(1):3219-3228. PubMed ID: 34266345
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.
    Song L, Li D, Gu Y, Wen ZM, Jie J, Zhao D, Peng LP.
    Clin Lung Cancer; 2016 Sep 01; 17(5):e65-e75. PubMed ID: 27236384
    [Abstract] [Full Text] [Related]

  • 15. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H, Qiao F, Wang Y, Xu Y, Shang Y.
    Oncol Rep; 2015 Nov 01; 34(5):2782-9. PubMed ID: 26351877
    [Abstract] [Full Text] [Related]

  • 16. Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway.
    Guo Z, Ye H, Zheng X, Yin W, He J.
    J Cell Physiol; 2021 May 01; 236(5):3808-3820. PubMed ID: 33258116
    [Abstract] [Full Text] [Related]

  • 17. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
    Yang WB, Zhang WP, Shi JL, Wang JW.
    Eur Rev Med Pharmacol Sci; 2018 Jun 01; 22(11):3408-3414. PubMed ID: 29917192
    [Abstract] [Full Text] [Related]

  • 18. miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway.
    Liu J, Xing Y, Rong L.
    Oncol Rep; 2018 Apr 01; 39(4):1631-1639. PubMed ID: 29484437
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration.
    Jiang DS, Wang YW, Jiang J, Li SM, Liang SZ, Fang HY.
    Int J Mol Med; 2014 Jul 01; 34(1):307-12. PubMed ID: 24788552
    [Abstract] [Full Text] [Related]

  • 20. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
    Li B, Ding CM, Li YX, Peng JC, Geng N, Qin WW.
    Oncol Rep; 2018 Mar 01; 39(3):1227-1234. PubMed ID: 29344640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.